Skip to search boxSkip to navigationSkip to main content

The discriminative stimulus properties of cocaine: effects of BAY K 8644 and nimodipine

  • Patrick M. Callahan
    ,
  • Kathryn A. Cunningham(corresponding author)
*Corresponding author for this work
  • University of Texas Medical Branch at Galveston
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Calcium channel blockers appear to reduce the cardiac toxicity of cocaine and some stimulant-induced behaviors. The present experiment was designed to test whether the internal state induced by cocaine is altered by the calcium antagonist nimodipine. Substitution tests with the calcium agonist BAY K 8644 were also conducted in rats (N = 8) trained to discriminate cocaine (10 mg/kg) from saline in a two-lever, water-reinforced drug discrimination paradigm. Cocaine (0.625-10 mg/kg) produced a dose-related increase in drug-lever responding while BAY K 8644 (0.25-2 mg/kg) and nimodipine (0.2-0.8 mg/kg) engendered primarily saline responding. In combination with cocaine (2.5-10 mg/kg), nimodipine shifted the cocaine dose-response curve to the right at doses of 0.2 and 0.4 mg/kg; this attenuation did not increase with higher doses of nimodipine (0.8 and 1.6 mg/kg). The present results suggest that nimodipine may partially block the discriminative stimulus properties of cocaine, however, this reduction is neither robust nor dose-related. Thus, nimodipine might be expected to only marginally alter the subjective cocaine state in humans.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 143-147 (5 pages)

Journal (Volume, Issue Number)

European Journal of Pharmacology (Volume 186, Issue 1)

Publication milestones

  • Published - 09/04/1990

Publication status

Published - 09/04/1990

ISSN

0014-2999

Publication IDs

  • Scopus: 0025040043
  • PubMed: 1704310

Publication metrics

Metrics

Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
16
Captures
2

Funding Details

Support for this research was provided by Miles Institute for Preclinical Pharmacological Research and the National Institute on Drug Abuse DA05708. We wish to thank Miles Pharmaceuticals for their generous gifts of BAY K 8644 and nimodipine. We also extend our thanks to Rosalba Luna for her assistance in preparing this manuscript.
FundersFunding number
Miles Institute for Preclinical Pharmacological Research
-
NIDA
R29DA005708